This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Santini, F. Articles by Pinchera, A. Search for Related Content PubMed PubMed Citation Articles by Santini, F. Articles by Pinchera, A.

Genetic Screening for Melanocortin-4 Receptor Mutations in a Cohort of Italian Obese Patients: Description and Functional Characterization of a Novel Mutation

Department of Endocrinology and Metabolism (F.S., G.C., C.P., G.S., V.R., A.M., S.L., M.T., P.A., C.M., P.V., A.P.), and Dulbecco Telethon Institute at Department of Endocrinology and Metabolism (M.M., C.C.), University of Pisa, 56124 Pisa, Italy; and Endocrinology Unit, University of Pavia, Fondazione Salvatore Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (L.C.), 27100 Pavia, Italy

Address all correspondence and requests for reprints to: Ferruccio Santini, M.D., Department of Endocrinology, University of Pisa, Via Paradisa, 2, 56124 Pisa, Italy. E-mail: fsantini{at}endoc.med.unipi.it.

Mutations in the human melanocortin-4 receptor (MC4-R) gene may account for up to 5.8% of morbid nonsyndromic obesity. We have screened 120 unrelated obese patients for variants of the MC4-R gene. Four heterozygous missense variants were detected, including two polymorphisms (Val¹⁰³Ile and Ile²⁵¹Leu) previously described in the literature. A novel heterozygous mutation (Glu³⁰⁸Lys) was detected in a 36-yr-old female patient. Compared with the wild-type receptor, cells expressing the mutated receptor showed a reduced stimulation of cAMP production and a reduction of radioactive MSH binding. No segregation of the mutation with the obese phenotype could be demonstrated. A second, potentially pathogenic mutation (Ser³⁰Phe) was detected in a 31-yr-old female patient. Functional analysis of the mutated receptor showed no change in the affinity to the natural ligand MSH nor limited ability to stimulate cAMP production. Sixty lean subjects were also screened, and no additional variants of the MC4-R gene were observed, except for two individuals with the Val¹⁰³Ile polymorphism. In conclusion, we have screened a population of Italian obese subjects for MC4-R variants, demonstrating a 1.7% prevalence of potentially pathogenic mutations. A novel heterozygous missense mutation (Glu³⁰⁸Lys) that impairs MC4-R functional activity in vitro was characterized.

This work was supported by the following grants: Ministero dell’Istruzione, dell’Università e della Ricerca Scientifica, Programmi di Ricerca Cofinanziati 2002: Obesity: Phenotype Characterization and Relationship with Pathogenesis; Ministero della Salute, Programma Speciale di Sperimentazione Spprovato nell’Anno 2000: Strategia Multidisciplinare per la Prevenzione e la Cura dell’Obesità e dei Disturbi del Comportamento Alimentare; Ministero dell’Istruzione, dell’Università e della Ricerca Scientifica, Centro di Eccellenza AmbiSEN: Effects of Envinromental Chemical Agents on the Endocrine and Nervous System; Telethon Foundation Contract Grant TCP99016 (to M.M.); a Telethon Fellowship (to C.C.), and an Assistant Telethon Scientist Award (to M.M.).

Abbreviations: BMI, Body mass index; MC4-R, melanocortin-4 receptor.

This article has been cited by other articles:

				R. Botta, S. Lisi, A. Pinchera, F. Giorgi, C. Marcocci, A. R. Taddei, A. M. Fausto, N. Bernardini, C. Ippolito, L. Mattii, et al. Sortilin Is a Putative Postendocytic Receptor of Thyroglobulin Endocrinology, January 1, 2009; 150(1): 509 - 518. [Abstract] [Full Text] [PDF]

				G. Liu, J.-P. Fortin, M. Beinborn, and A. S. Kopin Four Missense Mutations in the Ghrelin Receptor Result in Distinct Pharmacological Abnormalities J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1036 - 1043. [Abstract] [Full Text] [PDF]

				A. Hinney, T. Bettecken, P. Tarnow, H. Brumm, K. Reichwald, P. Lichtner, A. Scherag, T. T. Nguyen, P. Schlumberger, W. Rief, et al. Prevalence, Spectrum, and Functional Characterization of Melanocortin-4 Receptor Gene Mutations in a Representative Population-Based Sample and Obese Adults from Germany J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1761 - 1769. [Abstract] [Full Text] [PDF]

				C. Lubrano-Berthelier, B. Dubern, J.-M. Lacorte, F. Picard, A. Shapiro, S. Zhang, S. Bertrais, S. Hercberg, A. Basdevant, K. Clement, et al. Melanocortin 4 Receptor Mutations in a Large Cohort of Severely Obese Adults: Prevalence, Functional Classification, Genotype-Phenotype Relationship, and Lack of Association with Binge Eating J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1811 - 1818. [Abstract] [Full Text] [PDF]

				P. Buono, F. Pasanisi, C. Nardelli, L. Ieno, S. Capone, R. Liguori, C. Finelli, G. Oriani, F. Contaldo, and L. Sacchetti Six Novel Mutations in the Proopiomelanocortin and Melanocortin Receptor 4 Genes in Severely Obese Adults Living in Southern Italy Clin. Chem., August 1, 2005; 51(8): 1358 - 1364. [Abstract] [Full Text] [PDF]

				L. H. Larsen, S. M. Echwald, T. I. A. Sorensen, T. Andersen, B. S. Wulff, and O. Pedersen Prevalence of Mutations and Functional Analyses of Melanocortin 4 Receptor Variants Identified among 750 Men with Juvenile-Onset Obesity J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 219 - 224. [Abstract] [Full Text] [PDF]